Rare diseases
Investigational molecules
Locations
Back to France663 clinical trials in Grenoble, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Bulevirtide Treatment for Patients with Chronic Hepatitis D
FranceStudy on Dupilumab Step-Down Strategy for Maintaining Remission in Adults and Adolescents with Atopic Dermatitis
FranceStudy on Atezolizumab, Bevacizumab, and Paclitaxel for Advanced Lung Cancer Patients After Immunotherapy and Chemotherapy
FranceLong-Term Safety Study of Venetoclax for Patients with Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, Multiple Myeloma, or Acute Leukemia
FranceStudy on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients
FranceStudy on Surgery with or without Darolutamide for Patients with High-Risk or Locally Advanced Prostate Cancer
FranceStudy on Azacitidine and Gilteritinib for Adults with Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia
FranceStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
FranceStudy on the Effects of Ecopipam Hydrochloride for Children and Adolescents with Tourette's Disorder
FranceStudy Comparing DZD9008 and Chemotherapy for First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Mutation
FranceStudy of Relatlimab and Nivolumab for Patients with Advanced Liver Cancer Who Have Not Received Immunotherapy After Tyrosine Kinase Inhibitor Treatment
FranceStudy on Efzofitimod for Treating Pulmonary Sarcoidosis in Patients
FranceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on head and neck cancers, multiple myeloma, and various types of leukemia. Studies evaluate novel combination therapies and targeted treatments for improved patient outcomes.
Innovative approaches combining immunotherapy with standard treatments are showing promise in treating various forms of cancer.
Clinical investigations examining kidney transplant outcomes and rejection prevention. Research focuses on new therapeutic approaches for managing transplant-related complications.
Studies aim to improve transplant success rates and reduce rejection incidents through innovative medication protocols.
Research into narcolepsy and multiple sclerosis treatments, evaluating new therapeutic approaches for better symptom management and disease control.
Cutting-edge treatments being developed to address both rare and common neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
